Penumbra Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Welcome to the Morgan Stanley Healthcare Conference 2020 on our fourth day. And as I said in our earlier sessions this morning, we're sort of transitioning from a large-cap land into emerging growth land, even though some of these companies have become very large companies. And it's my pleasure to have with us here as we deal with not only emerging growth company and a very emerging growth market, Penumbra and their CEO and Founder, Adam Elsesser, who's been kind enough to be with us here for several years. And like every year, at the Morgan Stanley Healthcare Conference, Adam, I feel like there's always something very interesting to talk about and this year is no different.
Questions & Answers
But before we get to some of your emerging pipeline catalysts and some dynamics of the business, I just want to talk and start the same way as I've started with other CEOs at the conference the last 3 or 4 days, which is on recovery. And -- the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |